|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net income | |||||
| Depreciation and amortization | |||||
| Gain on sale of asset | |||||
| Net gain on marketable securities | |||||
| Allowance for credit losses | |||||
| Change in allowance for obsolete inventory | |||||
| Deferred income taxes | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Prepaid income taxes | |||||
| us-gaap_IncreaseDecreaseInAccountsPayable | |||||
| Accrued expenses | |||||
| Deferred revenue | |||||
| Income taxes payable | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisition of property, plant, and equipment | |||||
| Proceeds from sale of asset | |||||
| Proceeds from sale of marketable securities | |||||
| Purchase of marketable securities | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Dividends paid | |||||
| Net cash used in financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosure of cash flow information | |||||
| Taxes paid | |||||
| Supplemental disclosure of non-cash items: | |||||
| Dividends payable | |||||
Loading...
